143P Quality of life (QoL) with palbociclib (PAL) plus endocrine therapy (ET) versus (vs) capecitabine (CAP) in luminal metastatic breast cancer (MBC) patients (pts) in the PEARL study
Title:
143P Quality of life (QoL) with palbociclib (PAL) plus endocrine therapy (ET) versus (vs) capecitabine (CAP) in luminal metastatic breast cancer (MBC) patients (pts) in the PEARL study
Author:
Kahan, Z. Gil-Gil, M. Ruiz-Borrego, M. Carrasco, E.M. Ciruelos, E.M. Muñoz, M. Bermejo De Las Heras, B. Margeli Vila, M. Anton, A. Casas, M. Calvo, L. de la Haba, J. Ramos, M. Álvarez-López, I. Gal-Yam, E. Gautier, E. Corsaro, M. Rodrigálvarez, G. Zielinski, C. Martin Jimenez, M.